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Living alone was reported to be associated with increased risk of cardiovascular disease. There are, however, 
limited data on the relation between living alone and all-cause mortality in patients with acute myocardial 
infarction (AMI) undergoing percutaneous coronary intervention (PCI). The CREDO-Kyoto AMI registry was a 
cohort study of patients with AMI enrolled in 26 hospitals in Japan from 2005 through 2007. For the current 
analysis, we included those patients who underwent PCI within 24 hours of symptom onset and we assessed 
their living status to determine if living alone would be an independent prognostic risk factor. Among 4109 
patients eligible for the current analysis out of 5429 patients enrolled in the CREDO-Kyoto AMI registry, 515 
patients (12.5%) were living alone at the time of hospital admission. The cumulative 5-year incidence of 
all-cause death was 18.3% in the living alone group and 20.1% in the not living alone group (log rank P=0.77). 
After adjusting for potential confounders, risk of the living alone group relative to the not living alone group for 
all-cause death was not significantly different (adjusted hazard ratio: 0.82, 95% confidence interval 0.65-1.02; 
P=0.08). In a subgroup analysis stratified by age, the adjusted risk for all-cause d eath was also not different 
between the living alone group and the not living alone group both in the older population (>=75 years of age) 
and the younger population (<75 years of age). In conclusions, living alone was not associated with higher 
long-term mortality in patients with AMI who underwent PCI. 




  Living alone was reported to be associated with increased risk of cardiovascular disease1-4 and 
poorer clinical outcomes after acute myocardial infarction (AMI)5-10. However, the proportion of patients who 
had undergone percutaneous coronary intervention (PCI) was small in these studies. Indeed, some of the recent 
studies reported no significant association between living alone and mortality after AMI11, 12. Therefore, the 
association between living alone and long-term mortality in patients with AMI undergoing PCI in the current 
real world clinical practice is controversial. Additionally, living alone in older patients is an important welfare 
issue in rapidly aging societies. However, little is known about the influence of living alone in older patients on 
clinical outcomes after AMI. The aim of this study was to determine whether living alone is an independent 
prognostic risk factor for long-term mortality in patients with AMI who underwent PCI within 24 hours of 
symptom onset in the real world clinical practice.  
Methods 
The Coronary REvascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) AMI 
registry is a physician-initiated non-company-sponsored multicenter registry that enrolled consecutive patients 
with AMI who underwent coronary revascularization within seven days of the onset of symptoms between 
January 2005 and December 2007 at 26 tertiary hospitals in Japan (Supplementary Appendix A). The relevant 
review boards or ethics committees at all 26 participating hospitals approved the study protocol. Obtaining 
written informed consent from the patients was waived because of the retrospective nature of the study; however, 
we excluded those patients who refused participation in the study when contacted at follow-up. This strategy is 
concordant with the guidelines of the Japanese Ministry of Health, Labor and Welfare. 
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The details on the design and patient enrollment of this registry have been described previously13. 
Among 5429 patients enrolled in this registry, we excluded 9 patients who refused to participate in the study, 
195 patients treated by coronary artery bypass grafting (CABG), 689 patients who underwent PCI beyond 24 
hours after symptom onset, 30 patients whose symptom onset was unknown, 331 patients for whom the data on 
living arrangements was not available, and 66 patients who had previous CABG. Therefore, the study population 
for the current analysis consisted of 4109 patients with AMI who underwent PCI within 24 hours of symptom 
onset and for whom the data on living arrangements was available (ST segment elevation acute myocardial 
infarction [STEMI]: n=3615, Non-STEMI: n=494).  
Experienced clinical research coordinators from the independent clinical research organization 
(Research Institute for Production Development, Kyoto, Japan; Supplementary Appendix B) collected baseline 
clinical, angiographic and procedural characteristics including living arrangement from hospital charts or 
hospital databases according to pre-specified definitions. Collection of follow-up information was mainly 
conducted through review of inpatient and outpatient hospital charts by the clinical research coordinators, and 
additional follow-up information was collected through contact with patients, relatives and/or referring 
physicians by sending mail with questions regarding vital status, subsequent hospitalizations, and status of 
antiplatelet therapy. Death, myocardial infarction (MI), and stroke were adjudicated by the clinical event 
committee (Supplementary Appendix C). Median follow-up duration for the surviving patients was 1844 
(inter-quartile range [IQR]: 1508-2163) days. Complete 1- and 3-year follow-up information was obtained in 
98.3% and 96.2% of patients, respectively.   
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We defined living alone as patients who did not live with their family or others at the time of 
hospital admission. The detailed definitions of baseline clinical characteristics were described previously13, 14. 
The primary outcome measure for the current analysis was all-cause death. The secondary outcome measures 
included cardiac death, MI, stroke, hospitalization for congestive heart failure, and any coronary 
revascularization. Death was regarded as cardiac in origin unless obvious non-cardiac causes could be identified. 
Any death during hospitalization for the index AMI was regarded as cardiac death. MI was defined according to 
the definition in the Arterial Revascularization Therapy Study15. Stroke was defined as ischemic or hemorrhagic 
stroke either occurring during the index hospitalization or requiring hospitalization with symptoms lasting >24 
hours. Hospitalization for congestive heart failure was regarded as present when intravenous drug treatment was 
required for worsening heart failure. Any coronary revascularization was defined as either PCI or CABG for any 
reasons. Scheduled staged coronary revascularization procedures performed within 3 months of the initial 
procedure were not regarded as follow-up events, but were included in the index procedure.  
We present continuous variables as mean ± standard deviation or median with IQR and categorical 
variables as numbers and percentages. We compared categorical variables with the χ2 test when appropriate; 
otherwise, we used Fisher’s exact test. We compared continuous variables with the Student’s t-test or the 
Wilcoxon rank-sum test on the basis of the distributions. 
 We used the Kaplan-Meier method to estimate cumulative incidences of clinical event rates and 
assessed differences with the log-rank test. The effects of the living alone group relative to the not living alone 
group for individual endpoints were expressed as hazard ratios (HR) with 95% confidence intervals (CI) by 
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multivariable Cox proportional hazard models adjusting for the 40 clinically relevant factors indicated in Table 1, 
2 and 3. Consistent with our previous reports, continuous variables were dichotomized using clinically 
meaningful reference values or median values. A subgroup analysis stratified by patients’ age (>= 75 years old 
or < 75 years old) was also conducted. Statistical analyses were conducted using JMP 10.0 (SAS Institute Inc., 
Cary, North Carolina). All the statistical analyses were 2-tailed. We regarded P values <0.05 as statistically 
significant. 
Results 
Regarding the baseline clinical characteristics, the living alone group had significantly higher 
prevalence of patients with advanced age, female gender, history of heart failure, and liver cirrhosis (Table 1). 
The living alone group also had a significantly longer onset-to-presentation time compared with the not living 
alone group (Figure 1). However, there was no significant difference in the angiographic and procedural 
characteristics between the 2 groups except for the lower prevalence of multivessel coronary artery disease in the 
living alone group. Regarding medical treatment at discharge, beta-blockers were more often prescribed in the 
living alone group (Table 2 and 3).  
The cumulative incidence of all-cause death was not significantly different between the living alone 
and not living alone groups at 5 years (Figure 2A). After adjustment for potential confounding factors, the risk 
for all-cause death in the living alone group remained to be comparable with that in the not living alone group. 
The unadjusted and adjusted risk for cardiac death, MI, stroke, and any coronary revascularization were also not 
different between the 2 groups (Figure 2B, Supplemental Figure 1A, 1B and 1D). However, the cumulative 
incidence of readmission for heart failure in the living alone group was significantly higher than that in the not 
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living alone group, although the adjusted risk of the living alone group relative to the not living alone group for 
readmission for heart failure was not statistically significant (Supplemental Figure 1C and Table 4). 
 In the population of patients with <75 years of age, the cumulative 5-year incidence of all-cause 
death was not different between the living alone and the not living alone group. The cumulative incidence of all 
the other clinical endpoints were also not different between the 2 groups in the subgroup of patients with <75 
years of age (Table 4). On the other hand, the cumulative 5-year incidence of all-cause death and cardiac death 
in the living alone group were significantly lower than those in the not living alone group in the subgroup of 
patients with >=75 years of age. However, after adjusting the confounders, lower risk of the living alone group 
relative to the not living alone group for all-cause death was no longer significant in the subgroup of patients 
with >=75 years of age, although the adjusted risk for cardiac death in the living alone group remained 
significant. Regarding the other clinical endpoints, the adjusted outcomes between the living alone group and the 
not living alone group were not significantly different in the subgroup of patients with >=75 years of age (Table 
4).  
Discussion 
The main findings in this study were as follows; (1) Living alone was not associated with higher 
long-term mortality in patients with AMI who underwent PCI within 24 hours of symptom onset; (2) The risk 
for readmission for heart failure was also not significantly different between the living alone group and the not 
living alone group; (3) These results were consistently observed regardless of patients’ age. 
Living alone in older patients is an important welfare issue in the rapidly aging societies. The 
Statistics Bureau of Japan reported that percentage of people living alone in Japan was 11.3% in 2005 and 13.1% 
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in 2010 (12.5% in the current study)16. However, little is known about the influence of living alone in older 
patients on the clinical outcome after AMI. In previous studies, living alone was reported to be associated with 
increased risk of cardiovascular disease1-4 and poorer clinical outcomes after AMI5-10. However, most studies 
enrolled not only patients receiving primary PCI but also those with lytic therapy or those not receiving 
reperfusion therapy. Moreover, some of recent studies reported no significant association between living alone 
and mortality after AMI11, 12. Therefore, the association between living alone and long-term mortality after AMI 
in patients with PCI is controversial in the current real world clinical practice.  
In contrast to many previous reports, living alone was not associated with higher long-term mortality 
in patients with AMI who underwent PCI within 24 hours of symptom onset in the current study. One of the 
possible reasons for this discrepancy might be the difference in the baseline characteristics of the enrolled 
patients. The average of patients’ age in the current study was much higher than those in other studies, and all 
the patients in the current study received PCI in the AMI setting. In older population, patients living alone might 
be more likely to have good functional status, which has been reported to be a powerful predictor of survival in 
older people17-19. Another possible reason for the discrepancy between the current and previous studies might be 
the health insurance system in Japan, where public health insurance system covers everyone. Previous studies 
reported that patients living alone tended to have a higher unemployment rate and lower incomes3, 8, 11, 20, and 
other studies also reported that lower-income patients were less likely to receive primary PCI21, 22. Indeed, the 
recent study evaluating living arrangement and mortality after AMI in Japan also reported no significant 
difference in long-term mortality between the living alone and not living alone patients23.  
 As mentioned before, older patients living alone might be more likely to have good functional 
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status, which was a powerful predictor of survival in older people. On the other hand, patients living alone might 
have difficulties in receiving social support. These two factors might have directionally opposite impact on the 
relation between living arrangement and clinical outcome after AMI19. Furthermore, The current study as well as 
previous studies could not evaluate the patients living alone who suffered from AMI and died before hospital 
arrival. Indeed, the time from symptom onset to arrival to the hospital was much longer in patients living alone 
than those in patients not living alone in the current study. Total ischemic time was reported to be an important 
factor associated with long-term mortality in patients with STEMI undergoing primary PCI13. In this point of 
view, it would be important to reinforce the social welfare system to support the living alone patients in 
emerging setting.  
This study has several limitations. First, observational study design precluded definitive conclusions 
because of selection bias and unmeasured confounders. Second, we did not collect data on the changes in living 
arrangements after discharge from the index hospitalization, as well as functional, psychological, educational, 
and socioeconomic status, although those factors might be powerful predictors for mortality after AMI. 
Therefore, future well-conducted prospective studies in which those data are corrected will be desired. Third, 
practice style in Japan, such as longer length of hospital stay after AMI, is different from those outside Japan24. 
Finally, patient demographics and clinical outcomes in AMI patients with living alone in Japan may be also 
different from those outside Japan. Therefore, generalizing these results to populations outside Japan should be 
done with caution. 
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Legends to Figures 
 
Figure 1. Onset to presentation time and door to balloon time according to living arrangements.  
 
Figure 2. Clinical outcomes according to living arrangements. Cumulative incidences of all-cause death (A) and 
cardiac death (B) were compared between the living alone group and not living alone group. 
  
16 
Table 1. Baseline clinical characteristics according to living arrangements 
  Living alone Not living alone P value 
Variable (n = 515) (n = 3594)   
Age (years) 68.5 ± 13.0 67.6 ± 12.1 0.11 
    Age >=75 years* 196 (38%) 1097 (31%) 0.001 
Men* 322 (63%) 2701 (75%) <0.001 
Body mass index (kg/m2) <25.0* 390 (76%) 2586 (72%) 0.07 
Hypertension* 407 (79%) 2826 (79%) 0.84 
Diabetes mellitus  159 (31%) 1157 (32%) 0.55 
    on insulin therapy*  19 (3.7%) 160 (4.5%) 0.43 
Current smoker* 206 (40%) 1430 (40%) 0.93 
Heart failure* 188 (37%) 1093 (30%) 0.005 
Multivessel coronary disease* 243 (47%) 1884 (52%) 0.03 
Mitral regurgitation grade 3/4*  13 (2.5%) 115 (3.2%) 0.41 
Prior myocardial infarction*  44 (8.5%) 307 (8.5%) 0.99 
Prior percutaneous coronary intervention*   40 (7.8%) 316 (8.8%) 0.44 
Prior stroke (symptomatic)*  50 (9.7%) 331 (9.2%) 0.72 
Peripheral vascular disease*  17 (3.3%) 119 (3.3%) 0.99 
eGFR (ml/min/1.73 m2) < 30, without hemodialysis*  27 (5.2%) 150 (4.2%) 0.26 
Hemodialysis*  11 (2.1%)  52 (1.5%) 0.23 
Atrial fibrillation*  53 (10%) 333 (9.3%) 0.46 
Anemia (Hemoglobin <11.0 g/dl)*  62 (12%) 338 (9.4%) 0.06 
Thrombocytopenia (Platelet count <100,000)*  11 (2.1%)  65 (1.8%) 0.61 
Chronic obstructive pulmonary disease*  23 (4.5%) 113 (3.1%) 0.12 
Liver cirrhosis*  20 (3.9%)  76 (2.1%) 0.02 
Malignancy*  34 (6.6%) 293 (8.2%) 0.22 
Categorical variables are expressed as number (%) unless otherwise indicated. Continuous variables are shown as mean ± SD or median (interquartile range). 




Table 2. Presentation and Angiographic characteristics according to living arrangements 
  Living alone Not living alone P value 
Variable (n = 515) (n = 3594)   
ST-segment elevation myocardial infarction 453 (88%) 3162 (88%) 0.99 
Hours from onset to presentation  3.1 (1.3-6.4) 2.4 (1.2-5.3) 0.001 
                  <=2 hours 189 (39%) 1541 (45%) 0.01 
Minutes from door to balloon 90 (60-138) 96 (66-138) 0.16 
Hemodynamics:  
   
 Killip class 1 365 (71%) 2682 (75%) 0.04 
 Killip class 2  59 (11%) 279 (7.8%) 
 
 Killip class 3  14 (2.7%) 105 (2.9%) 
 
 Killip class 4*  77 (15%) 528 (15%) 
 
Duration of hospitalization (days)  15 (10-22)  15 (10-23) 0.06 
Infarct related coronary artery 
   
  Left anterior descending  249 (48%) 1602 (45%) 0.32 
  Left circumflex   69 (13%)  471 (13%) 
 
  Right  180 (35%) 1419 (40%) 
 
  Left main   13 (2.5%)   85 (2.4%) 
 
Number of target coronary narrowings 1 (1-2)  1 (1-2) 0.76 
Target of proximal Left anterior descending coronary artery* 286 (56%) 1909 (53%) 0.30 
Target of unprotected Left main coronary artery*  19 (3.7%) 131 (3.6%) 0.96 
Target of chronic total occlusion*  17 (3.3%) 122 (3.4%) 0.91 
Target of bifurcation* 146 (28%) 956 (27%) 0.40 
    Side-branch stenting*  14 (2.7%) 122 (3.4%) 0.42 
Total number of stents 1 (1-2) 1 (1-2) 0.97 
Total stent length >28mm* 207 (44%) 1422 (43%) 0.79 
Minimum stent size <3.0mm* 175 (37%) 1105 (34%) 0.13 
Drug eluting stent use (culprit or other lesions)* 151 (32%) 1092 (33%) 0.60 
Categorical variables are expressed as number (%) unless otherwise indicated. Continuous variables are shown as mean ± SD or median (interquartile range). 




Table 3. Medications at discharge according to living arrangements 
 
Living alone Not living alone P value 
Variable (n = 515) (n = 3594) 
 
Antiplatelet therapy 
   
   Thienopyridine 495 (96%) 3427 (95%) 0.44 
      Ticlopidine 443 (90%) 3164 (92%) 0.03 
      Clopidogrel  51 (10%)  259 (7.6%) 0.03 
   Aspirin 508 (99%) 3545 (99%) 0.99 
   Cilostazol* 158 (31%) 1266 (35%) 0.04 
Other medications 
   
   Statins* 260 (50%) 1930 (54%) 0.17 
   Beta-blockers* 238 (46%) 1465 (41%) 0.02 
   ACE-I/ARB* 368 (71%) 2622 (73%) 0.47 
   Nitrates* 168 (33%) 1081 (30%) 0.24 
   Calcium channel blockers* 103 (20%)  769 (21%) 0.47 
   Nicorandil* 148 (29%) 1002 (28%) 0.69 
   Warfarin*  45 (8.7%)  385 (11%) 0.17 
   Proton pump inhibitors* 185 (36%) 1259 (35%) 0.69 
   H2-blockers* 167 (32%) 1155 (32%) 0.90 
Categorical variables are expressed as number (%) unless otherwise indicated. Continuous variables are shown as mean ± SD or median (interquartile range). 
* Potential independent variables selected for Cox proportional hazard models. SD = standard deviation; 




Table 4. Clinical outcomes in patients living alone compared with patients not living alone 
Variable Living alone 
 







N of patients 
with events  
N of patients 









incidence)   
 (Cumulative 
incidence)    
HR 95% CI HR 95% CI 
 
(n = 515) 
 
(n = 3594) 
 




0.97 (0.79-1.19) 0.77 0.82 (0.65-1.02) 0.08 




0.94 (0.70-1.23) 0.65 0.78 (0.57-1.04) 0.10 




1.11 (0.73-1.62) 0.62 0.99 (0.63-1.48) 0.95 




0.94 (0.62-1.35) 0.73 0.96 (0.63-1.41) 0.82 




1.55 (1.16-2.04) 0.004 1.22 (0.88-1.65) 0.22 




1.00 (0.86-1.17) 0.99 1.11 (0.93-1.30) 0.24 
Patients <75 years of age (n = 319) 
 
(n = 2497) 
 




1.11 (0.79-1.53) 0.53 0.75 (0.50-1.09) 0.13 




1.23 (0.80-1.82) 0.34 0.91 (0.55-1.43) 0.68 




1.07 (0.60-1.77) 0.81 1.05 (0.57-1.79) 0.88 




0.69 (0.48-1.52) 0.69 0.92 (0.48-1.61) 0.78 




1.44 (0.88-2.23) 0.14 1.01 (0.59-1.66) 0.96 




0.80 (0.84-1.23) 0.80 1.12 (0.91-1.36) 0.28 
Patients >=75 years of age (n = 196) 
 
(n = 1097) 
 




0.71 (0.54-0.92) 0.009 0.79 (0.59-1.04) 0.10 




0.64 (0.43-0.91) 0.01 0.65 (0.42-0.97) 0.04 
 Myocardial infarction 13 (8.2%) 
 
 65 (8.0%) 
 
1.04 (0.55-1.82) 0.89 0.87 (0.43-1.62) 0.67 




0.82 (0.47-1.35) 0.45 0.96 (0.53-1.63) 0.87 




1.32 (0.92-1.86) 0.13 1.29 (0.84-1.92) 0.24 




1.00 (0.74-1.33) 0.98 1.12 (0.80-1.53) 0.49 
Cumulative incidence was estimated by the Kaplan-Meier method.  




























Onset to presentation time
90 (60-138) 96 (66-138)



















































Interval 0 days 30 days 1 year 3 years 5 years
Living alone
N of events 21 44 65 87
N of patients at risk 515 490 449 406 251
Cumulative incidence 4.1 % 8.7 % 13.1 % 18.3 %
Not Living alone
N of events 198 358 516 693
N of patients at risk 3594 3384 3190 2967 1880
Cumulative incidence  5.5 % 10.0 % 14.5 % 20.1 %
Follow-up interval (years)
Log rank P = 0.77  
Living alone
Not living alone




0                    1                    2                    3                    4                    5                        1                    2                     3                    4                   5                        
Interval 0 days 30 days 1 year 3 years 5 years
Living alone
N of events 21 34 42 49
N of patients at risk 515 490 449 406 251
Cumulative incidence 4.1 % 6.7 % 8.5 % 10.2 %
Not Living alone
N of events 194 292 353 405
N of patients at risk 3594 3384 3190 2967 1880
Cumulative incidence  5.4 % 8.2 % 10.0 % 11.8 %
